Human Infectuous Disease - 1262 Words

Human infectious diseases are diseases caused by pathogens, disease causing microorganisms. These diseases can range from mild to fatal and have different modes of transmission and modes of action. It is the potential negative implications of such diseases that has made many of them among the main targets for the World Health Organization. Since the human body does not have B-cells that produce antibodies specific to all types of antigenic pathogens, the body cant fight all types of infectious diseases. Hence, vaccinations and forms of treatment that may employ inducing artificial immunity are sometimes needed, immediately. Infectious human diseases can be transmitted in many ways depending on the type of the disease, these include skin contact, breathing, water, blood transfusion, sexual intercourse, transmittance through other organisms, most commonly a mosquito, and many other modes of transmission. These diseases may also range n symptoms and Signs and may even develop latently in the body. In this research paper an infectious disease will be explored in depth from its cause, to symptoms to virulence, to forms of treatment and prevention. The Disease Among the most widely known and feared human infectious diseases comes Cholera. Cholera is an infectious disease that has had 7 recorded pandemic outbreaks over the past 2 centuries, taking away millions of lives from across the globe. It is an acute ( critical) intestinal infection that causes copious watery diarrheaShow MoreRelatedGlaxosmithkline18561 Words   |  75 Pagescompany profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figures for 2003 (in  £ million)